J. Boyle

Polycom, Inc. develops video, voice and content collaboration and communication technology. It offers consult, deployment, customer support, optimization, managed and cloud services. The firm serves healthcare, education, entertainment, government and finance industries. It offers solutions through Polycom RealPresence platform. The company was founded by Brian L. Hinman and Jeffrey Rodman in December 1990 and is headquartered in San Jose, CA.

Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ.

Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA.

Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.

LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle.